Ormat Technologies, Inc. (ORA)
Valuation Overview•Is Ormat Technologies, Inc. Overvalued or Undervalued?
Priced at a premium to peer multiples and intrinsic cash flows, demanding strong execution to justify current levels.
Fragile underlying quality score of 33/100; weak margins or elevated debt leverage warrant caution.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Mixed fundamental profile with offsetting strengths and weaknesses.
Wall Street is broadly bullish, projecting solid upside alongside robust expected earnings growth. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
ORA struggles with subpar profitability and pressured margins. However, this is severely offset by a highly leveraged balance sheet (Debt/EBITDA > 4.0x) and elevated financial risk.
The company demonstrates solid revenue growth (10.5% 3Y CAGR) paired with robust earnings compounding (20.0% EPS 3Y CAGR). Operating efficiency remains adequate with margins around 7.1%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $403.9M | +12.5% | +10.5% | +7.0% | +5.2% | |
| EBITDA | -$4.1M | — | +10.2% | — | — | |
| Net Income | $44.1M | +0.1% | +23.5% | — | +0.4% | |
| EPS (Diluted) | $0.71 | -1.0% | +20.0% | +4.1% | -1.9% | |
| Free Cash Flow | -$35.2M | +22.9% | -0.3% | -38.6% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 27.5% | 30.1% | 33.4% | 35.9% |
| Operating Margin | 7.1% | 19.4% | 20.9% | 24.7% |
| Net Margin | 11.0% | 13.9% | 12.0% | 13.6% |
| FCF Margin | -26.2% | -36.0% | -40.7% | -23.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.92 | $1.30 | +41.3% | ||
| Q1'26 | $0.67 | $0.67 | +0.0% | ||
| Q4'25 | $0.37 | $0.41 | +10.8% | ||
| Q3'25 | $0.37 | $0.48 | +29.7% | ||
| Q2'25 | $0.58 | $0.68 | +17.2% | ||
| Q1'25 | $0.47 | $0.72 | +53.2% | ||
| Q4'24 | $0.31 | $0.42 | +35.5% | ||
| Q3'24 | $0.36 | $0.40 | +11.1% |
Total return is +50.8% (1Y), outperforming the benchmark by +25.9%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +12.5% | +3.2% | — |
| 1Y | +50.8% | +25.9% | +0.6% |
| 3YCAGR | +15.2% | -4.8% | +1.7% |
| 5YCAGR | +14.8% | +1.0% | +3.7% |
| 10YCAGR | +11.8% | -1.8% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Ormat Technologies, Inc. (ORA) valuation, health, and returns.
Ormat Technologies, Inc. is estimated to be overvalued under our discounted cash flow framework. relative multiples indicate the stock is Expensive versus peers compared to industry peers. overvalued (implying -45.1% downside from DCF intrinsic value of $70.04)
Ormat Technologies, Inc. has multiple valuation anchors: DCF Intrinsic Value: $70.04 | Peer Relative Fair Value: $29.77 | Wall Street Analyst Target: $138.86 (implying +8.8% upside). A convergence of these signals offers higher conviction.
Ormat Technologies, Inc. displays weak financial health with a composite quality score of 33/100, supported by a Piotroski F-Score of 4/9, Return on Invested Capital (ROIC) of 2.7%.
Ormat Technologies, Inc. pays a 0.4% dividend yield, covered by a 23% payout ratio with 0 years of growth, supplemented by a 0.0% buyback yield.
Ormat Technologies, Inc.'s current growth trajectory is Accelerating. The company achieved +12.5% 1Y revenue growth and -1.0% 1Y EPS growth, compared to its 3Y revenue CAGR of +10.5%.
Wall Street consensus is Hold based on 17 analysts, beating EPS expectations in 83% of recent quarters with a 1-quarter streak. The consensus price target represents a +8.8% change from current levels.
Investment risks for Ormat Technologies, Inc. include: -20.1% 1-year max drawdown. Volatility risk is characterized by a beta of 0.87x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.